Literature DB >> 9417448

[Treatment of recurrent epistaxis in Rendu-Osler-Weber disease].

J A Werner1, U W Geisthoff, B M Lippert, H Rudert.   

Abstract

Rendu-Osler-Weber disease is an autosomally dominant inherited disease which affects the connective tissue of blood vessels. The major symptom is recurrent epistaxis for which still exists no generally recommended treatment. Treatment modalities discussed in the literature include bilateral closure of the nostrils, brachytherapy, vessel embolization, hormone therapy, dermoplasties, as well as different kinds of laser therapies. Advantages and disadvantages of single treatment modalities are discussed. Dermoplasty and laser therapy seem to be the most suitable treatment procedures currently available for recurrent epistaxis in affected patients. Treatment carried out with the argon, KTP or ND:YAG laser has proven to be suitable as initial therapy. In most cases the additional use of long-term applications of a soft nasal ointment allows a lasting successful treatment. Our experiences show that dermoplasty should be reserved for cases with continued bleeding despite laser treatment but only rarely offers a long-term cure in the sense of a total recovery from epistaxis.

Entities:  

Mesh:

Year:  1997        PMID: 9417448     DOI: 10.1007/s001060050141

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  5 in total

Review 1.  Life-threatening bleeding after tooth extraction due to vascular malformation: a case report and literature review.

Authors:  Marcus Stephan Kriwalsky; Dimitrios Papadimas; Peter Maurer; Martin Brinkmann; Jochen Jackowski; Martin Kunkel
Journal:  Oral Maxillofac Surg       Date:  2014-04-23

2.  [Diagnosis and treatment of Osler's disease].

Authors:  F Haubner; T Kühnel
Journal:  HNO       Date:  2018-05       Impact factor: 1.284

3.  The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study.

Authors:  Benedikt J Folz; Ana Cerra Wollstein; Heiko Alfke; Anja A Dünne; Burkard M Lippert; Konrad Görg; Hans-Joachim Wagner; Siegfried Bien; Jochen A Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-12-17       Impact factor: 2.503

4.  Trauma Can Induce Telangiectases in Hereditary Hemorrhagic Telangiectasia.

Authors:  Urban Geisthoff; Ha-Long Nguyen; Rolf Lefering; Steffen Maune; Kruthika Thangavelu; Freya Droege
Journal:  J Clin Med       Date:  2020-05-17       Impact factor: 4.241

5.  Update on Clinical Strategies in Hereditary Hemorrhagic Telangiectasia from an ENT Point of View.

Authors:  Kornelia E C Wirsching; Thomas S Kühnel
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.